Beyond MABEL: An Integrative Approach to First in Human Dose Selection of Immunomodulators by the Health and Environmental Sciences Institute (HESI) Immuno‐Safety Technical Committee (ITC)Mineo Matsumoto, Jean G. Sathish, Rutwij A. Dave et al.|Clinical Pharmacology & Therapeutics|2024Cited by 15